MiR-328 has been shown to negatively regulate the expression of ABCG2 in human cancer cells, while miR-199a-3p has been shown to induce cell cycle arrest, reduce invasion, and increase doxorubicin sensitivity by negatively regulating mTOR and c-Met [25,26]. This evidence concerns the gene ABCG2 and cancer.